Mangoceuticals (MGRX) Price to Sales (2023 - 2026)

Mangoceuticals has disclosed Price to Sales across 4 years of filings, most recently posting 99.58 for Q2 2026.

• In Q2 2026, Price to Sales rose 3.46% year-over-year to 99.58; the TTM figure through Jun 2026 stood at 21.72 (down 30.73% YoY), while the FY2025 annual figure was 16.34, up 110.18% from the prior year.
• Price to Sales came in at 99.58 for Q2 2026 at Mangoceuticals, up from 90.03 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 299.58 in Q3 2025 to a low of 18.26 in Q4 2023.
• Average Price to Sales over 4 years is 96.23, with a median of 80.46 recorded in 2025.
• Year-over-year, Price to Sales slumped 81.22% in 2024 and soared 428.73% in 2025.
• Over 4 years, Price to Sales stood at 18.26 in 2023, then soared by 149.25% to 45.5 in 2024, then surged by 73.58% to 78.98 in 2025, then advanced by 26.07% to 99.58 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 99.58 in Q2 2026, 90.03 in Q1 2026, and 78.98 in Q4 2025.